Skip to content

Chapters ENES DE

XExtension Codes
Substances
XM6S30Medicaments
XM5MU9Systemic antibiotics, anti-infectives or antiparasitics
Antivenin, antivenom (sera), Immunoglobulin
XM1RS8Immunoglobulins
XM5YM7Specific immunoglobulins

XM0QB1 category

Motavizumab

Also indexed as

Motavizumab

Nearby in Specific immunoglobulins

XM4361Anti-D (rh) immunoglobulin
XM8824Tetanus immunoglobulin
XM6JK2Hepatitis B immunoglobulin
XM5R25Rabies immunoglobulin
XM8Q08Vaccinia immunoglobulin
XM3FU2Pertussis immunoglobulin
XM8Z30Mumps immunoglobulin
XM7X82Varicella zoster immunoglobulin

PreviousXM45N8 — Palivizumab NextXM0U74 — Raxibacumab

Browse ICD-11

01Certain infectious or parasitic diseases
02Neoplasms
03Diseases of the blood or blood-forming organs
04Diseases of the immune system
05Endocrine, nutritional or metabolic diseases
06Mental, behavioural or neurodevelopmental disorders
07Sleep-wake disorders
08Diseases of the nervous system
09Diseases of the visual system
10Diseases of the ear or mastoid process
11Diseases of the circulatory system
12Diseases of the respiratory system
13Diseases of the digestive system
14Diseases of the skin
15Diseases of the musculoskeletal system or connective tissue
16Diseases of the genitourinary system
17Conditions related to sexual health
18Pregnancy, childbirth or the puerperium
19Certain conditions originating in the perinatal period
20Developmental anomalies
21Symptoms, signs or clinical findings, not elsewhere classified
22Injury, poisoning or certain other consequences of external causes
23External causes of morbidity or mortality
24Factors influencing health status or contact with health services
25Codes for special purposes
26Supplementary Chapter Traditional Medicine Conditions
VSupplementary section for functioning assessment
XExtension Codes
Histopathology
Dimensions of injury
Dimensions of external causes
Consciousness
Substances
Diagnosis code descriptors
Capacity or context
Health Devices, Equipment and Supplies
Extension codes of particular relevance to skin diseases
5 more
XM6S30Medicaments
XM9N55Substances, chiefly nonmedicinal
Allergens
XM6CH2Drugs primarily affecting the autonomic nervous system
XM7YD4Drugs used in addictive disorders
XM8014Antivertigo and motion sickness preparations
XM1950Agents primarily acting on smooth and skeletal muscles or the respiratory system
XM5MU9Systemic antibiotics, anti-infectives or antiparasitics
XM0QJ8Neuroprotective agents, not elsewhere classified
XM7BA9Analgesics, antipyretics or anti-inflammatory drugs
XM7452Antiepileptics or antiparkinsonism drugs
XM0HK5Antipsychotics [neuroleptics]
14 more
Systemic antibiotics and antibacterials
Antimycobacterials
Antifungal agents
Antiviral drugs
Antivenin, antivenom (sera), Immunoglobulin
Vaccines
Other specified systemic anti-infectives and antiparasitics
Antiprotozoal drugs
Anthelminthics
XM8MX1Serum antitoxic
XM9QJ7Serum convalescent
XM0SJ2Serum protective
XM5CC6Spider antivenin
XM2042Tetanus toxoid or vaccine antitoxin
XM2GK5Tetanus toxoid or vaccine immune globulin (human)
XM8Y67Vaccine antineoplastic
XM6VF9Immune sera
XM1RS8Immunoglobulins
29 more
XM0AQ7Immunoglobulins, normal human
XM5YM7Specific immunoglobulins
XM1BS2Immunoglobulin not elsewhere classified
XM3NK9Antiviral monoclonal antibodies
XM8Z30Mumps immunoglobulin
XM7X82Varicella zoster immunoglobulin
XM3ZS8Rubella immunoglobulin
XM1V63Staphylococcus immunoglobulin
XM7NM9Cytomegalovirus immunoglobulin
XM4YT6Diphtheria immunoglobulin
XM7LD1Hepatitis A immunoglobulin
XM5NX5Encephalitis, tick borne immunoglobulin
XM1GU6Measles immunoglobulin
XM45N8Palivizumab
XM0QB1Motavizumab
XM0U74Raxibacumab
XM8Y60Anthrax immunoglobulin
XM6GD5Bezlotoxumab
XM54X9Obiltoxaximab
6 more

International Classification of Diseases, Eleventh Revision (ICD-11), World Health Organization (WHO) 2019/2021, https://icd.who.int/browse11. Licensed under Creative Commons Attribution-NoDerivatives 3.0 IGO (CC BY-ND 3.0 IGO).

Release 2026-01. View this entity in the official WHO ICD-11 browser.

This page reproduces WHO classification content for reference. It is not medical advice and must not be used to diagnose or treat. For coding decisions, consult the official release and your national coding guidelines.

About · Data & methodology · Privacy · Contact